STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Company

ENANTA PHARMACEUTICALS INC

Filed

March 14, 2025

Period of Report

March 13, 2025

Accession Number

0001062993-25-005504